Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Similar to the guideline but the toxicity is not evaluated. The objective was to define the best sampling time for the guideline.

Data source

Reference
Reference Type:
publication
Title:
An optimal, generalized sampling time of 30 ± 6 h after double dosing in the mouse peripheral blood micronucleus test
Author:
Higashikuni N, Sutou S
Year:
1995
Bibliographic source:
Mutagenesis 10(4): 313-319

Materials and methods

Test guidelineopen allclose all
Qualifier:
equivalent or similar to guideline
Deviations:
yes
Remarks:
toxicity is not assessed
Guideline:
EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
Principles of method if other than guideline:
Additional sampling time were included in the study
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Diethyl sulphate
EC Number:
200-589-6
EC Name:
Diethyl sulphate
Cas Number:
64-67-5
Molecular formula:
C4H10O4S
IUPAC Name:
diethyl sulfate
Details on test material:
supplier: Nacalai Tesque Inc (Japan)

Test animals

Species:
mouse
Strain:
other: MS/Ae
Sex:
male/female

Administration / exposure

Route of administration:
intraperitoneal
Duration of treatment / exposure:
Injected twice, at 24 h interval.
Frequency of treatment:
see above
Post exposure period:
24 to 60 h after the 2nd treatment
Doses / concentrations
Remarks:
Doses / Concentrations:
80 and 160 mg/kg
Basis:
nominal conc.
No. of animals per sex per dose:
5
Control animals:
other: Same animals, sampling time before treatment

Examinations

Tissues and cell types examined:
reticulocytes

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
positive
Toxicity:
not examined
Vehicle controls validity:
not specified
Negative controls validity:
valid
Positive controls validity:
not examined

Any other information on results incl. tables

Dose
(mg/kg)

Sampling time (h)

Number of animals

Mean MN/1000 RET

SD

80

0

5

3.20

1.64

24

8.60

1.67

30

9.00

5.10

36

7.40

2.07

42

5.60

2.07

48

2.80

1.92

54

2.20

2.49

60

2.20

1.92

160

0

5

3.00

1.00

24

4

8.75

2.87

30

15.50

3.32

36

13.25

2.50

42

9.75

2.06

48

8.75

2.36

54

6.75

1.26

60

2.75

1.50

MN = micronucleated cell

RET = reticulocytes

SD = standard deviation

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): positive
DES induced micronucleus in the reticulocytes of mouse. Peak responses are observed around 30 h after the second treatment.
Executive summary:

A micronucleus test was performed in mice treated by ip with 80 or 160 mg/kg (2 injections). Sampling time was between 24 and 60 h after the second injection.

In the conditions of this test, DES induced micronucleus, the peak response was between 34 and 36 h.